Global Active Implantable Medical Devices Market Analysis and Forecast Report 2030

$5,000$10,000

Global Active Implantable Medical Devices Market: Market Segments: By Product Type (Implantable Cardioverter Defibrillators, Neurostimulators, Implantable Cardiac Pacemakers, Implantable Hearing Devices, Ventricular Assist Devices, Implantable Heart Monitors/Insertable Loop Recorders); and Region – Analysis of Market Size, Share & Trends for 2014 – 2019 and Forecasts to 2030

Clear

Description

global Active Implantable Medical Devices Market

Product overview
Active implantable medical device refers to any active medical device that is intended to be inserted in a natural orifice, completely or partially, surgically or medically, into the human body or by medical intervention, and which is intended to stay in place after the operation. AIMDs are subject to both pre-and post-market strict regulatory controls. Active implantable medical devices are operated devices that are implanted, either through a natural orifice or through surgical means, into the body of a patient and are intended to stay after the operation in the patient’s body. Usually, such instruments are battery-powered, and the power supply may be either contained in the instrument or attached to wires protruding from the body of the patient. Implementations in this group range from blood oxygen level monitor to sophisticated heart-lung devices that can take over the cardiopulmonary functions of a patient during surgery.

Market Highlights
Global Active Implantable Medical Devices Market to surpass USD XXXX million by 2030 from USD XXXX million in 2018 at a CAGR of XX% throughout the forecast period, i.e. 2019-30.
The key growth drivers for the implantable and life-sustaining devices market are factors such as aging population growth, increasing prevalence of cardiovascular and neurological disorders, investments and funds for the production of technologically advanced goods, expanded applications of neurostimulators, and favorable reimbursement scenarios for ENT procedures in developed countries. In addition, rising chronic diseases and developments in successful implantable medical devices are expected to fuel the growth of the market over the forecast period.

Global Active Implantable Medical Devices Market: Segments
Implantable cardioverter-defibrillators Segment to grow with the highest CAGR of XX.X% during 2019-30
Global Active Implantable Medical devices market is segmented by product type into implantable cardioverter defibrillators, neurostimulators, implantable cardiac pacemakers, implantable hearing devices, ventricular assist devices, implantable heart monitors/insertable loop recorders. Implantable cardioverter-defibrillators, which further divided into transvenous implantable cardioverter defibrillators and subcutaneous implantable cardioverter defibrillators, held the largest share in the global active implantable medical devices market in 2018, owing to the rising incidence of cardiovascular diseases, the production of technologically advanced devices in developing countries and the increasing demand for these devices. Transvenous implantable cardioverter defibrillators, which further segmented into biventricular implantable cardioverter defibrillators, dual-chamber implantable cardioverter defibrillators and single-chamber implantable cardioverter defibrillators held largest market share in the global active implantable cardioverter defibrillators market in 2018, as compared to subcutaneous implantable cardioverter defibrillators.

The neurostimulators market is expected to witness the highest growth during the forecast period owing to the significant increase in demand for neurostimulators, especially deep brain stimulators, across the globe. The growing prevalence of chronic pain, such as neuropathic pain, diabetes pain, arthritis pain, and injury pain, is increasing the demand for neurostimulators significantly.

Global Active Implantable Medical Devices Market: Market Dynamics
Drivers
Increasing prevalence of cardiovascular diseases and neurological disorders
Key factors such as the growing prevalence of cardiovascular diseases and the increasing incidence of neurological disorders, the market for active implantable medical devices is increasing. The leading cause of premature death around the world is cardiovascular disease. The primary medical devices used to treat various cardiovascular disorders are implantable cardioverter defibrillators and implantable cardiac pacemakers. One of the important drivers of market growth is the growing geriatric population. Moreover, rising chronic diseases are expected to fuel market growth in accordance with developments in successful implantable medical devices.

Increasing R&D investments
The increasing burden of cardiovascular and neurological diseases and investments and funds to develop technologically advanced goods, as well as growing R&D funding for healthcare and increasing R&D developments in emerging economies, are some of the factors that drive market growth. In the future, due to the growing number of patients with cardiovascular diseases and neurological disorders, rising spending on healthcare is expected to fuel demand for active implantable medical devices worldwide over the next few years.

Restrain
High cost of Active Implantable Medical Devices products

High implantable medical device costs and unfavorable reimbursement policies, concerns related to the use of implantable medical devices, and high costs are key obstacles that hinder the implementation of solutions for active implantable medical devices. However, growing demand for non-invasive treatments, implantable device-related complications and high device costs are expected to hinder market growth over the coming years.

Global Active Implantable Medical Devices Market: Regions
Global Active Implantable Medical devices market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, APAC and MENA.
Global Active Implantable Medical devices market in North America held the largest market share of XX.X% in the year 2018. North America holds the largest share is primarily attributed to the growth in the geriatric population, increasing prevalence of cardiovascular and neurological diseases, high accessibility to advanced technologies, increasing development of innovative and technologically advanced products, and increasing healthcare expenditure in the region. However, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Growth in the Asia-Pacific market can be attributed to the growth in the geriatric population, growing incidence of chronic diseases, rising healthcare spending, healthcare reforms for infrastructural development, growing demand for advanced technologies to develop advanced products, and less stringent regulations.

Competitive Landscape:
The Global Active Implantable Medical Devices market, which is highly competitive, consists of several major players such as Medtronic plc, Abbott Laboratories, and Boston Scientific Corporation hold a substantial market share in the Global Active Implantable Medical Devices market. Other players analyzed in this report are Medtronic plc (Ireland) and Nurotron Biotechnology Co. Ltd. (China) among others

Recently, various developments have been taking place in the market. For instance, In May 2016, Boston Scientific Corporation launched the Precision Montage MRI Spinal Cord Stimulator (SCS) System after receiving approval from the U.S. Food and Drug Administration. The Precision Montage System offers customized relief to patients with chronic pain, while also enabling safe access to full-body magnetic resonance imaging (MRI) in a 1.5 Tesla environment.

Global Active Implantable Medical DevicesMarket is further segmented by region into:
North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
APAC Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
MENA Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA

Global Active Implantable Medical Devices Market: Key players
Abbott Laboratories
Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis
Biotronik Se & Co., Kg
Boston Scientific Corporation
Cochlear Limited
Livanova PLC
Med-EL
Medtronic PLC
Nurotron Biotechnology Co. Ltd.
William Demant Holding A/S

Global Active Implantable Medical Devices Market report also contains analysis on:
Global Active Implantable Medical Devices Market Segments:
By Product:

Implantable Cardioverter Defibrillators
Transvenous Implantable Cardioverter Defibrillators
Biventricular Implantable Cardioverter Defibrillators/Cardiac Resynchronization Therapy Defibrillators
Dual-Chamber Implantable Cardioverter Defibrillators
Single-Chamber Implantable Cardioverter Defibrillators
Subcutaneous Implantable Cardioverter Defibrillators
Neurostimulators
Spinal Cord Stimulators
Deep Brain Stimulators
Sacral Nerve Stimulators
Vagus Nerve Stimulators
Gastric Electrical Stimulators
Implantable Cardiac Pacemakers
Implantable Hearing Devices
Active Hearing Implants
Non-active/Passive Hearing Implants
Ventricular Assist Devices
Implantable Heart Monitors/Insertable Loop Recorders
Active Implantable Medical Devices Market Dynamics
Active Implantable Medical Devices Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints

Related Reports: Implantable Medical Devices Market Global Industry Analyses 2016-2020 an opportunity forecasted 2020-2030

Additional information

Publisher

Geography Covered

Date Published

,

Pages

Format

Table of Contents

Contents
1. Executive Summary
2. Global Active Implantable Medical Devices Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Global Active Implantable Medical Devices Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Global Active Implantable Medical Devices Market
11.1. Market Size & forecast, 2019A-2030F
11.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12. Global Active Implantable Medical Devices Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada)
12.1.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.2. Europe: (Brazil, Mexico, Argentina, Rest of Latin America)
12.1.2.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.3. Asia-Pacific: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe)
12.1.3.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.4. LATAM: (Brazil, South Africa, Saudi Arabia, U.A.E. and Other Countries)
12.1.4.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.5. MEA: (Brazil, South Africa, Saudi Arabia, U.A.E. and Other Countries)
12.1.5.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2. By Product: Market Share (2020-2030F)
12.2.1. Implantable Cardioverter Defibrillators, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.2. Neurostimulators, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.3. Implantable Cardiac Pacemakers, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.4. Implantable Hearing Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.5. Ventricular Assist Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.6. Implantable Heart Monitors/Insertable Loop Recorders, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
13. Company Profile
13.1. Abbott Laboratories
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Biotronik Se & Co., Kg
13.3. Boston Scientific Corporation
13.4. Cochlear Limited
13.5. Livanova PLC
13.6. Med-EL
13.7. Medtronic PLC
13.8. Nurotron Biotechnology Co. Ltd.
13.9. William Demant Holding A/S
13.10. Other Prominent Players
Consultant Recommendation
**The above-given segmentation and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

Reviews

There are no reviews yet.

Be the first to review “Global Active Implantable Medical Devices Market Analysis and Forecast Report 2030”